Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8791-8800 Newer>

Chemistry World March 17, 2014 Eleanor Merritt	Four steps to asthma treatment Scientists based in the US have devised a new way to make Montelukast, a drug used in the treatment of asthma and seasonal allergies.
Chemistry World March 14, 2014 Phillip Broadwith	Bristol-Myers Squibb to close Irish plant BMS tied the closure to 'changing market demand' for its products, along with efforts to optimize its manufacturing network.
Chemistry World March 7, 2014 Emma Stoye	Convicted chemist was 'sole bad actor' at US drug lab An investigation by the Massachusetts state inspector general has concluded that Annie Dookhan, the US forensic chemist imprisoned last year for falsifying thousands of drug tests, was the 'sole bad actor' at her former workplace.
Pharmaceutical Executive March 3, 2014 Sillup & Porth	Pharm Exec: Annual Press Audit 2014 Pharm Exec's latest survey of press issues shows that media coverage continues to remain on balance negative toward the industry, by a slight margin: 47% this year compared to a 46% average over the last seven years.
Pharmaceutical Executive March 3, 2014 Mason Tenaglia	The New Metrics of Market Success Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else?
Pharmaceutical Executive March 1, 2014 William Looney	The Call to Community: A Conversation with Dr. David Nash Population health is the foundation for much of what is truly new in US health reform. For big Pharma, it represents yet another escalation in expectations.
Pharmaceutical Executive March 1, 2014 Jill Wechsler	Data disclosure, integrity challenge pharma Transparency initiatives are multiplying, affecting research, marketing and compliance.
Pharmaceutical Executive March 1, 2014 William Looney	The Community Ethic Regardless of how you define it, partnership is also an institutional necessity as big Pharma adjusts to disruptive changes in the way health services are financed and delivered.
Chemistry World February 26, 2014 Ned Stafford	Roche disputes unethical East German trial claims Clinical trials in the 1980s, performed in former communist East Germany by global pharmaceutical giant Hoffmann-La Roche, adhered to international standards and did not violate East German laws, according to a report issued by the company after a six month internal investigation.
Chemistry World February 25, 2014 Sarah Houlton	Megamerger brings Actavis into R&D race Generic drug giant Actavis is to buy speciality pharmaceutical firm Forest Labs in a deal worth about $25 billion, bringing Actavis into the drug discovery business.
<Older 8791-8800 Newer> Return to current articles.